Perspective Therapeutics (AMEX:CATX) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.31) by 19.35 percent. This is a 4.17 percent decrease over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $342.00 thousand which beat the analyst consensus estimate of $144.30 thousand by 137.01 percent. This is a 5.23 percent increase over sales of $325.00 thousand the same period last year.